Protein analysis firm Zephyrus Biosciences launched this week with Kelly Gardner as CEO, Josh Molho as chief technology officer, Brock Siegel as chief operating officer, Gary Zweiger as chief business development officer, Jenny Rooke as chief marketing officer, and Chris Hadsell as chief financial officer.
Katleen Verleysen is stepping down as CEO of protein biomarker firm Pronota following the company's absorption into MyCartis, its joint venture with Biocartis. Verleysen will be moving to a consultant role with clients including Biocartis and other life science firms.
BG Medicine said this week that it has let go included Senior Vice President, Executive Operations and Human Resources, Anastasia Rader. Her layoff comes as part of a larger restructuring in which the company laid-off 12 of its 22 employees.